If you live in Delaware and are looking into compounded GLP-1 medications, the practical questions tend to be the same three: is this legal here, how does the care actually work, and what does it really cost. This page answers all three. It walks through Delaware’s telehealth statute and what it requires of any prescriber treating a Delaware patient, explains the permit rules for pharmacies that ship compounded medication into the state, and lists what real providers, national telehealth services and Delaware clinics alike, currently charge. Every price in the comparison table comes from the provider’s own public pages, checked on the dates shown in the table.
One disclosure before anything else: this site is operated by Gentle Health, a telehealth provider of compounded semaglutide and tirzepatide. Gentle Health appears in the comparison table below on the same terms as every other provider.
How compounded GLP-1 access works in Delaware
Delaware allows a physician to establish care with a new patient entirely by telehealth, provided the physician can meet the same standard of care as an in-person visit. The details of the statute are covered in the next section; here is what the process looks like in practice at Gentle Health:
- You complete a health intake online. It covers your medical history, current medications, any prior experience with GLP-1 therapy, and your goals for weight management.
- James Simmons, MD reviews your case. Dr. Simmons is licensed to practice in Delaware through the Interstate Medical Licensure Compact (license C1-0029948, state board record), the expedited licensing pathway Delaware adopted in Chapter 17A of its professional licensing code. A Compact license is a full Delaware medical license, not a limited or provisional one, according to the IMLC. Dr. Simmons evaluates whether treatment is appropriate for you, and not everyone qualifies.
- If treatment is appropriate, a prescription goes to a licensed compounding pharmacy. The pharmacy prepares the medication for you specifically and ships it to your Delaware address, whether that is Wilmington, Newark, Dover, Middletown, or Rehoboth Beach.
- Follow-up continues by telehealth. Dose adjustments, side effect questions, and check-ins happen with Dr. Simmons, the same physician who evaluated you, not a rotating roster of unnamed staff.
The program is cash-pay, with pricing published further down this page. There is no insurance billing and no membership fee layered on top of the medication cost.
Eligibility details and license verification for Delaware are on our Delaware page. Whether a Delaware patient begins with an asynchronous review or a scheduled video visit is covered in how our initial prescribing process varies by state.
Delaware rules worth knowing
Delaware regulates this category from two directions, the prescriber and the pharmacy, with federal compounding rules sitting on top of both.
Telehealth prescribing. Delaware’s telehealth and telemedicine rules live in Chapter 60 of Title 24 of the Delaware Code, and they are more detailed than most states’. The essentials:
- A provider-patient relationship is required before care can be delivered by telehealth, and the statute expressly allows that relationship to be established through telehealth itself, so long as the provider “is able to meet the same standard of care as if the health-care services were being provided in-person” (§ 6003(b)).
- Establishing the relationship requires specific steps: verifying the patient’s location and identity, disclosing the provider’s identity and credentials, obtaining informed consent to telehealth, establishing a diagnosis through acceptable medical practices, discussing treatment options and their risks, arranging follow-up coverage, and giving the patient a written visit summary (§ 6003(a)).
- Absent a proper provider-patient relationship, Delaware flatly prohibits issuing prescriptions “solely in response to an internet questionnaire, an internet consult, or a telephone consult” (§ 6003(c)). A legitimate telehealth practice clears this bar by doing a real evaluation; a questionnaire mill does not. At Gentle Health, each Delaware intake is reviewed individually by James Simmons, MD, who makes the treatment decision; no prescription is issued off a questionnaire alone.
- Before diagnosis and treatment, the provider must do at least one of the following: an in-person exam, a diagnosis made using audio or visual communication, having another Delaware-licensed provider present with the patient, or meeting the telemedicine practice standards of the applicable professional societies (§ 6004(a)). Once the relationship is properly established, later visits with the same provider do not need to repeat these steps.
- Delaware permits both synchronous and asynchronous (store-and-forward) telehealth, and it allows audio-only visits when a patient cannot access video (§ 6001, § 6003(b)).
One Delaware-specific wrinkle worth knowing: physicians licensed in a state that has not adopted an applicable interstate compact can only treat Delaware patients by telehealth if they obtain an interstate telehealth registration from the Division of Professional Regulation (§ 6002(c)). That pathway is not relevant to Gentle Health, because Dr. Simmons holds a full Delaware license through the Compact, but it is a useful question to ask any telehealth service: is your prescriber actually licensed or registered in Delaware? The Center for Connected Health Policy maintains a plain-language summary of Delaware’s telehealth rules if you want the overview version.
The pharmacy side. Most compounded GLP-1 prescriptions for Delaware patients are filled by out-of-state compounding pharmacies, and Delaware regulates these directly. Under Subchapter IV of Delaware’s pharmacy statute, a pharmacy located outside Delaware that delivers, dispenses, or distributes prescription drugs to a patient in the state must hold a Delaware nonresident pharmacy permit. The conditions attached to that permit (24 Del. C. § 2537) include disclosing the pharmacists who dispense into Delaware, forwarding inspection reports from the home state’s regulator, keeping Delaware patients’ dispensing records readily retrievable, and staffing a toll-free pharmacist line at least six days a week. In short, the pharmacy filling your prescription answers to the Delaware Board of Pharmacy, not just its home state’s board. As of this update, the Delaware Board of Pharmacy has not published GLP-1-specific guidance that we could locate; the general nonresident-permit and compounding rules above are what govern.
The federal backdrop. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage in February 2025, and has since clarified its policies for compounders as supply stabilized. Mass compounding of copies of commercially available products has wound down, and in 2026 the agency has moved to further restrict bulk compounding of these ingredients by outsourcing facilities, as reported by Pharmacy Times. What remains is traditional patient-specific compounding under Section 503A: a licensed prescriber writes a prescription for an individual patient based on that patient’s clinical needs, and a state-licensed pharmacy fills it. That is the pathway legitimate providers, Gentle Health included, operate under. Compounded medications are not FDA-approved, and any provider that buries that fact is not being straight with you.
Compounded semaglutide in Delaware
Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your body releases after eating, which slows stomach emptying, moderates blood sugar, and reduces appetite. Compounded semaglutide is that active ingredient prepared by a licensed compounding pharmacy for an individual patient, dispensed in a vial for injection or in an oral form, rather than in a manufacturer’s fixed-dose pen. Compounded medications are not FDA-approved, and clinical trial results for brand-name products do not transfer to compounded versions.
For Delaware patients, Gentle Health offers compounded semaglutide in two forms:
- Oral semaglutide: starting at $112 per month. No needles. A daily form for people who want the lower-cost starting point or simply prefer not to inject.
- Injectable semaglutide: starting at $135 per month. A once-weekly subcutaneous injection, shipped with supplies.
Both prices are cash-pay and dose-tiered. There is no membership fee, published prices for each prescribed dose tier, and no insurance paperwork, because insurance is not billed at all. Whether semaglutide is appropriate for you, and at what dose, is Dr. Simmons’s call after reviewing your health history. Treatment is subject to medical evaluation, and some patients, such as those with a personal or family history of medullary thyroid carcinoma, are not candidates.
Compounded tirzepatide in Delaware
Tirzepatide works on two receptors rather than one: GLP-1 and GIP, a second gut hormone involved in appetite and metabolism. Compounded tirzepatide, like compounded semaglutide, is prepared by a licensed compounding pharmacy for a specific patient under a physician’s prescription, and it is not FDA-approved.
Gentle Health offers injectable compounded tirzepatide starting at $169 per month, cash-pay, with the same structure as the semaglutide program: evaluation and ongoing care by James Simmons, MD, medication shipped from a licensed compounding pharmacy to your Delaware address, and no membership fee on top. Tirzepatide is typically the more expensive of the two medications across the market, as the table below shows, so the practical question for many patients is whether to start with semaglutide and reassess later. That is a conversation to have during your evaluation, not a decision to make from a pricing page.
Provider options in Delaware: comparison table
Methodology: providers listed alphabetically; all prices taken from each provider’s own public pages on July 27, 2026, with spot-rechecks on July 30, 2026; where a price is not published, we write “See site” rather than guessing.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves Delaware | Insurance | Source |
|---|---|---|---|---|---|---|
| Gentle Health | Telehealth; care by James Simmons, MD | From $112 (oral) / From $135 (injectable) | From $169 (injectable) | Yes | Cash-pay only; insurance not billed | gentle.health (verified 2026-07-30) |
| Henry Meds | Telehealth; medication plus provider access | See site (site FAQ: GLP-1 plans from $179/mo) | See site | See site (state availability confirmed at signup) | Not required; cash-pay | henrymeds.com (verified 2026-07-30) |
| Lavish Wellness & Aesthetics | In-person; Wilmington clinic with weekly injection visits | GLP-1 injection program: $550/mo ($125/week injection plus $50 provider visit); site does not identify the medication or state whether it is compounded | GLP-1/GIP injection: $175/week; site does not identify the medication or state whether it is compounded | Yes (Wilmington) | See site | livelavishde.com (verified 2026-07-30) |
| Medi-Weightloss Wilmington/Talleyville | In-person clinic visits; Concord Pike, Wilmington | $99 first month (offer); membership plans from $199/mo plus $199 new-patient visit; ongoing medication pricing: See site | $199 first month (offer); ongoing medication pricing: See site | Yes (Wilmington) | Accepts insurance for visits; HSA/FSA eligible | mediweightloss.com (verified 2026-07-27) |
| Mochi Health | Telehealth; membership plus medication billed separately | From $99 medication + $79/mo membership ($39 first month) | From $199 medication + $79/mo membership | See site | See site | joinmochi.com (verified 2026-07-30) |
| OrderlyMeds | Telehealth; all-inclusive plans | $149 after starter (from $74 starter) | $299 after starter (from $149 starter) | Yes (site states providers licensed in all 50 states) | Not required; cash-pay | orderlymeds.com (verified 2026-07-27) |
A few honest notes on reading this table. These care models are genuinely different, not just differently priced. The two Wilmington clinics bundle in-person visits with the medication, weekly in one case, which some people value and others do not need. Mochi separates its membership fee from the medication, so the real monthly cost runs higher than the headline medication price. OrderlyMeds uses introductory pricing that steps up after the first period, Henry Meds does not publish clear standard per-medication prices on its public pages, and Medi-Weightloss publishes first-month offers without listing standard ongoing medication prices. Gentle Health’s numbers are dose-tiered monthly prices with no membership fee. None of these structures is objectively right; they suit different people, which is why we list them rather than rank them.
For a year-long, all-fees-included view of how the major programs price out, see our full comparison of what GLP-1 programs actually cost.
Delaware FAQ
Is compounded semaglutide legal in Delaware?
Yes, through the patient-specific pathway. A prescriber licensed for Delaware writes a prescription for an individual patient, and a compounding pharmacy fills it. If that pharmacy sits outside Delaware, it must hold a Delaware nonresident pharmacy permit under Subchapter IV of the state pharmacy statute before it can ship medication to a Delaware address. Compounded medications are not FDA-approved.
Can a doctor really prescribe this in Delaware without seeing me in person?
Yes. Delaware’s telehealth statute (24 Del. C. Chapter 60) allows a provider-patient relationship to be established by telehealth, at the same standard of care as an in-person visit, and prescribing to follow from it. What Delaware does not allow is a prescription issued solely off an internet questionnaire without a proper relationship. The statute spells out what a real telehealth evaluation must include: identity verification, informed consent, an actual diagnosis through acceptable medical practices, a discussion of options, and a written visit summary.
Who actually provides my care at Gentle Health if I’m in Delaware?
James Simmons, MD. He is licensed in Delaware through the Interstate Medical Licensure Compact, which Delaware has adopted into its licensing code. He performs the initial evaluation, writes the prescription if treatment is appropriate, and handles follow-up care and dose adjustments. There is no handoff to a rotating group of prescribers.
Will my insurance or Delaware Medicaid cover compounded GLP-1s?
Generally no. Insurance plans, including Delaware Medicaid, rarely cover compounded medications, which is why this market is almost entirely cash-pay. Gentle Health does not bill insurance; the listed figures are starting-tier prices; the dose-tier table below shows the full monthly cost at each prescribed dose. If your plan covers brand-name GLP-1 therapy, that is worth exploring with your own physician and insurer, and it is a different product and pathway from anything on this page.
How does the medication get to me in Delaware?
After Dr. Simmons approves treatment, the prescription goes to a licensed compounding pharmacy holding a Delaware nonresident permit, which ships the medication and supplies to your address anywhere in the state, from Claymont to Fenwick Island. Cold-chain packaging is standard for injectable peptides. Delaware’s permit rules also require that pharmacy to staff a pharmacist phone line you can actually reach, at least six days a week.
I live in Delaware but work in Philadelphia or Maryland. Does that matter?
It can. Telehealth rules generally attach to where the patient is physically located at the time of the visit, and each state licenses separately. If you are a Delaware resident, do your telehealth visits from Delaware. If you genuinely split your time across state lines, raise it during your evaluation so care is set up correctly from the start.
Why do Delaware prices range from about $112 to over $600 a month for what sounds like similar medication?
Because you are not just buying medication; you are buying a care structure. The top of the range in Wilmington includes a weekly in-person clinic visit with the injection administered for you. The middle of the range often carries membership fees or post-introductory price steps. The lower end, including Gentle Health’s starting-tier $112 oral semaglutide, is telehealth care with medication shipped to you and no bundled extras. Compare what is actually included, not just the headline number.
Current Gentle Health dose tiers and pricing
Gentle Health pricing depends on the dose tier prescribed by your clinician. Current monthly prices are:
Oral compounded semaglutide
| Tier | Daily dose | Monthly price |
|---|---|---|
| Starting | 2-4 mg/day | $112/mo |
| Medium | >4-8 mg/day | $189/mo |
| High dose | >8-12 mg/day | $258/mo |
Injectable compounded semaglutide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 0.24-0.48 mg/wk | $135/mo |
| Medium | >0.48-1.2 mg/wk | $159/mo |
| High dose | >1.2-2.4 mg/wk | $199/mo |
Injectable compounded tirzepatide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 2.5-5 mg/wk | $169/mo |
| Medium | >5-10 mg/wk | $219/mo |
| High dose | >10-15 mg/wk | $269/mo |
Medication, the initial review by a licensed clinician, video visits and messaging, and overnight refrigerated shipping are included. There is no separate membership fee, and HSA and FSA cards are accepted. Your clinician determines the appropriate medication and dose; the monthly price changes if the prescribed dose moves into a different tier.
Gentle Health serves patients across a growing multistate footprint through clinicians licensed in each patient’s jurisdiction, including Delaware.
Reviewed by James Simmons, MD
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.